Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia.
Eliel NhamKyungmin HuhYou Min SohnHyo Jung ParkHyemee KimSook Young WooJae-Hoon KoSun Young ChoCheol-In KangDoo Ryeon ChungHee Jae HuhHyung-Doo ParkNam Yong LeeKyong-Ran PeckPublished in: BMC infectious diseases (2022)
≥ 13.94 μg/mL during the initial 72 h was associated with higher 30-day mortality in enterococcal bacteremia. Further studies are warranted to elucidate optimal pharmacokinetic targets for enterococcal bacteremia.